New GMiA code of practice
September 27, 2013
The Generic Medicines Industry
Association yesterday released a
new edition of its Code of Practice,
and is seeking feedback from
industry stakeholders.
The draft third edition of the
Code incorporates a number
of amendments, including
recommendations from the
Working Group on Promotion of
Therapeutic Products which were
reported to the then Parliamentary
Secretary for Health, Catherine
King, in March 2011.
The Code Complaint Committee
has been adjusted to increase its
independence, with all industry
representatives removed.
GMiA members will continue to
report on educational events and
“non-price benefits,” and reports
will now cover the period 01 July-
30 June rather than the Oct-Sep
period of the current Code.
The draft third edition of the
Code introduces the concept
of a “Complying Member” of
the Association, each of which
must “pro-actively opt to comply
with the Code” and provide a
declaration of compliance.
All current GMiA members
have confirmed their intent to be
“Complying Members”.
The draft Code also requires
that GMiA hold an annual training
workshop covering the contents of
the Code and Members’ obligations.
GMiA said the code is “principle
based, providing guidance in a
single document on the different
legislation, regulation and
guidelines with which sponsors
of generic medicines listed on the
ARTG comply”.
Feedback on the draft third
edition is invited up until 31 Oct -
CLICK HERE for details.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Sep 13To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Sep 13
